Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Net Income (2017 - 2025)

Historic Net Income for CollPlant Biotechnologies (CLGN) over the last 9 years, with Q3 2025 value amounting to -$3.5 million.

  • CollPlant Biotechnologies' Net Income rose 2278.73% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 20342.86%. This contributed to the annual value of -$16.5 million for FY2024, which is 14558.3% down from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Net Income of -$3.5 million as of Q3 2025, which was up 2278.73% from $3.2 million recorded in Q2 2025.
  • CollPlant Biotechnologies' 5-year Net Income high stood at $71.9 million for Q3 2021, and its period low was -$192.6 million during Q4 2021.
  • Over the past 5 years, CollPlant Biotechnologies' median Net Income value was -$3.0 million (recorded in 2021), while the average stood at -$6.4 million.
  • Examining YoY changes over the last 5 years, CollPlant Biotechnologies' Net Income showed a top increase of 69875.44% in 2021 and a maximum decrease of 52956.61% in 2021.
  • Over the past 5 years, CollPlant Biotechnologies' Net Income (Quarter) stood at -$192.6 million in 2021, then surged by 97.57% to -$4.7 million in 2022, then fell by 8.38% to -$5.1 million in 2023, then rose by 21.59% to -$4.0 million in 2024, then grew by 11.75% to -$3.5 million in 2025.
  • Its Net Income stands at -$3.5 million for Q3 2025, versus $3.2 million for Q2 2025 and $1.6 million for Q1 2025.